<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37854789</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2377-9608</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><PubDate><Year>2023</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>SAGE open nursing</Title><ISOAbbreviation>SAGE Open Nurs</ISOAbbreviation></Journal><ArticleTitle>Symptom Experience and Perceived Health Status of People With Long COVID in Thailand.</ArticleTitle><Pagination><StartPage>23779608231206748</StartPage><MedlinePgn>23779608231206748</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">23779608231206748</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/23779608231206748</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Despite the World Health Organization declaring COVID-19 no longer a public health emergency, reports of long COVID persist globally, raising concerns about its impact on individuals.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This retrospective study aimed to explore the symptom experiences of individuals with long COVID-19 and examine the relationship between those experiences and perceived negative health status in Thailand.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The study focused on individuals with moderate to severe COVID-19 infections. Between July 3, 2022 and December 1, 2022, we conducted telephone interviews with 86 individuals who tested positive for SARS-CoV-2 and received outpatient care in Bangkok. The COVID-19 Yorkshire Rehabilitation Screening was utilized to measure symptom occurrence, duration, severity, and health status on an 11-point numerical rating scale from 0 (none or excellent) to 10 (the worst). A Spearman rank correlation was used to analyze the relationships between long COVID symptoms and negative perception of health status.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among the participants, 75.6% had long COVID, with a median of three symptoms lasting for a median duration of 5.6 months. Difficulties in performing daily activities were most common, reported by 50.8% of participants. The majority (80.0%) experienced itching, headache, cognition, muscle pain, continence, and sleeping problem for 6 months. Loss of taste was the most severe symptom, with a mean severity rating of 8.8. There were significant positive relations between a negative perception of health status and multiple symptoms, symptom severity, functional disability, and additional symptoms.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Individuals with moderate to severe COVID-19 infection who experienced long COVID had poorer perceived health status. To effectively manage and improve the health status of individuals with long COVID, nurses should provide follow-up care, assess not only the occurrence of symptoms but also their duration and severity, and evaluate performance outcomes.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pumipak</LastName><ForeName>Bangern</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Disease Control, Institute for Urban Disease Control and Prevention, Nonthaburi, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jittimanee</LastName><ForeName>Sirinapha</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3828-5075</Identifier><AffiliationInfo><Affiliation>Faculty of Nursing, Chulalongkorn University, Bangkok, Thailand.</Affiliation><Identifier Source="RINGGOLD">65104</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thananun</LastName><ForeName>Sirima</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Disease Control, Institute for Urban Disease Control and Prevention, Nonthaburi, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathong</LastName><ForeName>Kaewjai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Disease Control, Institute for Urban Disease Control and Prevention, Nonthaburi, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poungdok</LastName><ForeName>Jomtien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Disease Control, Institute for Urban Disease Control and Prevention, Nonthaburi, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinsap</LastName><ForeName>Manthana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Disease Control, Institute for Urban Disease Control and Prevention, Nonthaburi, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sueathong</LastName><ForeName>Thatsanee</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Disease Control, Institute for Urban Disease Control and Prevention, Nonthaburi, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kongruang</LastName><ForeName>Oranong</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Disease Control, Institute for Urban Disease Control and Prevention, Nonthaburi, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faungprachakorn</LastName><ForeName>Sujitraporn</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Disease Control, Institute for Urban Disease Control and Prevention, Nonthaburi, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thunyaphun</LastName><ForeName>Thunyarut</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Disease Control, Institute for Urban Disease Control and Prevention, Nonthaburi, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Insook</LastName><ForeName>Poramate</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Faculty of Nursing, Rajamangala University of Technology Thanyaburi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soontornmon</LastName><ForeName>Kaewalee</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Disease Control, Rayong Occupational Health and Environmental Development Center (ROHED Center), Nonthaburi, Thailand.</Affiliation><Identifier Source="RINGGOLD">213865</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>SAGE Open Nurs</MedlineTA><NlmUniqueID>101724853</NlmUniqueID><ISSNLinking>2377-9608</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">health status</Keyword><Keyword MajorTopicYN="N">impact</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">symptom experience</Keyword></KeywordList><CoiStatement>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>19</Day><Hour>4</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37854789</ArticleId><ArticleId IdType="pmc">PMC10580730</ArticleId><ArticleId IdType="doi">10.1177/23779608231206748</ArticleId><ArticleId IdType="pii">10.1177_23779608231206748</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aiyegbusi O. L., Hughes S. E., Turner G., Rivera S. C., McMullan C., Chandan J. S., Haroon S., Price G., Davies E. H., Nirantharakumar K., Sapey E., Calvert M. J., &amp; TLC Study Group. (2021). Symptoms, complications and management of long COVID: A review. Journal of the Royal Society of Medicine, 114(9), 428&#x2013;442. 10.1177/01410768211032850</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun M. C., Singh A. K., Pal D., Das K., Alekhya G., Venkateshan M., Mishra B., Patro B. K., Mohapatra P. R., Subba S. H. (2022). Characteristics and predictors of long COVID among diagnosed cases of COVID-19. PLoS ONE, 17(12), 1&#x2013;14. 10.1371/journal.pone.0278825</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0278825</ArticleId><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="pubmed">36538532</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K. G., Brokstad K. A., Zhou F., Linchausen D. W., Hansen B. A., Lartey S., Onyango T. B., Kuwelker K., S&#xe6;vik M., Bartsch H., T&#xf8;ndel C., Kittang B. R., Bergen COVID-19 Research Group, Cox R. J., Langeland N. (2021). Long COVID in a prospective cohort of home-isolated patients. Nature Medicine, 27(9), 1607&#x2013;1613. 10.1038/s41591-021-01433-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha C., Baek G. (2021). Symptoms and management of long COVID: A scoping review. Journal of Clinical Nursing, 1&#x2013;18. 10.1111/jocn.16150</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.16150</ArticleId><ArticleId IdType="pubmed">34913540</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E., McCorkell L., Vogel J. M., Topol E. J. (2023). Long COVID: Major findings, mechanisms and recommendations. Nature Reviews Microbiology, 21, 133&#x2013;146. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira J. F., de &#xc1;vila R. E., de Oliveira N. R., da Cunha Severino Sampaio N., Botelho M., Gon&#xe7;alves F. A., Neto C. J. F., de Almeida Milagres A. C., Gomes T. C. C., Pereira T. L., de Souza R. P., Molina I. (2022). Persistent symptoms, quality of life, and risk factors in long COVID: A cross-sectional study of hospitalized patients in Brazil. International Journal of Infection Diseases, 122, 1044&#x2013;1051. 10.1016/j.ijid.2022.07.063</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.07.063</ArticleId><ArticleId IdType="pmc">PMC9330427</ArticleId><ArticleId IdType="pubmed">35908724</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Disease Control (2023, June 28). COVID-19 situation in Thailand on a weekly basis. https://ddc.moph.go.th/covid19-dashboard/.</Citation></Reference><Reference><Citation>Devellis R. (2012). Scale Development Theory and Applications. Sage Publications.</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Florencio L. L., Cuadrado M. L., Plaza-Manzano G., Navarro-Santana M. (2021). Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. European Journal of Internal Medicine, 95, 55&#x2013;70. 10.1016/j.ejim.2021.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S. J., McIvor C., Whyatt G., Adams A., Harvey O., McLean L., Walshaw C., Kemp S., Corrado J., Singh R., Collins T., O'Connor R. J., Sivan M. (2021). Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. Journal of Medical Virology, 93(2), 1013&#x2013;1022. 10.1002/jmv.26368</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J. H., Womack K. N., Tenforde M. W., Files D. C., Gibbs K. W., Shapiro N. I., Prekker M. E., Erickson H. L., Steingrub J. S., Qadir N., Khan A., Hough C. L., Johnson N. J., Ely E. W., Rice T. W., Casey J. D., Lindsell C. J., Gong M. N., Srinivasan V., Lewis N. M., &#x2026; Influenza and Other Viruses in the Acutely Ill (IVY) Network. (2022). Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress. Influenza and Other Respiratory Viruses, 16(4), 680&#x2013;689. 10.1111/irv.12980</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12980</ArticleId><ArticleId IdType="pmc">PMC9111447</ArticleId><ArticleId IdType="pubmed">35347854</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero-Montes M., Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Ferrer-Pargada D., Tello-Mena S., Cancela-Cilleruelo I., Rodr&#xed;guez-Jim&#xe9;nez J., Palacios-Ce&#xf1;a D., Par&#xe1;s-Bravo P. (2022). Prevalence of neuropathic component in post-COVID pain symptoms in previously hospitalized COVID-19 survivors. International Journal of Clinical Practice, 2022, 1&#x2013;6. 10.1155/2022/3532917</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/3532917</ArticleId><ArticleId IdType="pmc">PMC9159239</ArticleId><ArticleId IdType="pubmed">35685491</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Pinto M. D., Borelli J. L., Mehrabadi M. A., Abrahim L. H., Dutt N., Lambert N., Nurmi E. L., Chakraborty R., Rahmani A. M., Downs C. A. (2022). COVID Symptoms, symptom clusters, and predictors for becoming a long-hauler looking for clarity in the haze of the pandemic. Clinical Nursing Research, 31(8), 1390&#x2013;1398. 10.1177/10547738221125632</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10547738221125632</ArticleId><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabbari P., Taraghikhah N., Jabbari F., Ebrahimi S., Rezaei N. (2022). Body mass index as a predictor of symptom duration in COVID-19 outpatients. Disaster Medicine and Public Health Preparedness, 17, 1&#x2013;4. 10.1017/dmp.2022.185</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/dmp.2022.185</ArticleId><ArticleId IdType="pmc">PMC9509789</ArticleId><ArticleId IdType="pubmed">35924444</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenz E. R., Pugh L. C., Milligan R. A., Gift A., Suppe F. (1997). The middle-range theory of unpleasant symptoms: An update. Advances in Nursing Science, 19(3), 14&#x2013;27. 10.1097/00012272-199703000-00003</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00012272-199703000-00003</ArticleId><ArticleId IdType="pubmed">9055027</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xed;&#x161;ka D., Liptakov&#xe1; E., Babi&#x10d;ov&#xe1; A., Batalik L., Ba&#x148;&#xe1;rov&#xe1; P. S., Dobrodenkov&#xe1; S. (2022). What is the quality of life in patients with long COVID compared to a healthy control group? Frontiers in Public Health, 10, 1&#x2013;9. 10.3389/fpubh.2022.975992</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.975992</ArticleId><ArticleId IdType="pmc">PMC9667067</ArticleId><ArticleId IdType="pubmed">36408018</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P. A., Cuapio A., Villapol S. (2021). More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Scientific Reports, 11, 1&#x2013;12. 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connor R. J., Preston N., Parkin A., Makower S., Ross D., Gee J., Halpin S. J., Horton M., Sivan M. (2022). The COVID-19 Yorkshire rehabilitation scale (C19-YRS): Application and psychometric analysis in a post-COVID-19 syndrome cohort. Journal of Medical Virology, 94(3), 1027&#x2013;1034. 10.1002/jmv.27415</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27415</ArticleId><ArticleId IdType="pmc">PMC8662016</ArticleId><ArticleId IdType="pubmed">34676578</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahony L., Buwalda T., Blair M., Forde B., Lunjani N., Ambikan A., Neogi U., Barrett P., Geary E., O'Connor N., Dineen J., Clarke G., Kelleher E., Horgan M., Jackson A., Sadlier C. (2022). Impact of long COVID on health and quality of life. HRB Open Research, 5, 31. 10.12688/hrbopenres.13516.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/hrbopenres.13516.1</ArticleId><ArticleId IdType="pmc">PMC9440374</ArticleId><ArticleId IdType="pubmed">36101871</ArticleId></ArticleIdList></Reference><Reference><Citation>Partiprajak S., Krongthaeo S., Piaseu N., Wongsathikun J., Kongsuwan A. (2023). The Thai version of the COVID-19 Yorkshire rehabilitation scale: A valid instrument for the psychometric assessment of the community members in Bangkok, Thailand. BMC Public Health, 23(1), 663. 10.1186/s12889-023-15566-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-15566-2</ArticleId><ArticleId IdType="pmc">PMC10088103</ArticleId><ArticleId IdType="pubmed">37041552</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis R. H., Santillana M., Ognyanova K., Safarpour A., Lunz Trujillo K., Simonson M. D., Green J., Quintana A., Druckman J., Baum M. A., Lazer D. (2022). Prevalence and correlates of long COVID symptoms among US adults. JAMA Network Open, 5(10), 1&#x2013;11. 10.1001/jamanetworkopen.2022.38804</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson M. M., Qasmieh S. A., Kulkarni S. G., Teasdale C. A., Jones H. E., McNairy M., Borrell L. N., Nash D. (2023). The epidemiology of long COVID in US adults. Clinical Infectious Diseases, 76(9), 1636&#x2013;1645. 10.1093/cid/ciac961</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac961</ArticleId><ArticleId IdType="pubmed">36542514</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad N. J., Moek F., Steitz F., Murajda L., B&#xe4;rnighausen T., Zoller T., P&#xf6;rtner K., Muller N. (2021). A longitudinal study on symptom duration and 60-clinical course in non-hospitalised COVID-19 cases in Berlin, Germany, March to May, 2020. Euro Surveillance, 26(43), 1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8555372</ArticleId><ArticleId IdType="pubmed">34713798</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarda R., Kumar A., Chandra A., Bir M., Kumar S., Soneja M., Sinha S., Wig N. (2022). Prevalence of long COVID-19 and its impact on quality of life among outpatients with mild COVID-19 disease at tertiary care center in north India. Journal of Patient Experience, 9, 1&#x2013;7. 10.1177/23743735221117358</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/23743735221117358</ArticleId><ArticleId IdType="pmc">PMC9358596</ArticleId><ArticleId IdType="pubmed">35957651</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverberg J. I., Zyskind I., Naiditch H., Zimmerman J., Glatt A. E., Pinter A., Theel E. S., Joyner M. J., Hill D. A., Lieberman M. R., Bigajer E., Stok D., Frank E., Rosenberg A. Z. (2022). Predictors of chronic COVID-19 symptoms in a community-based cohort of adults. PLoS ONE, 17(8), 1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352033</ArticleId><ArticleId IdType="pubmed">35925904</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L., Tosto-Mancuso J., Wood J., Cortes M., Kontorovich A., McCarthy D., Rizk D., Rozanski G., Breyman E., Nasr L., Kellner C., Herrera J. E., Putrino D. (2022). Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health related quality of life, and participation. American Journal of Physical Medicine &amp; Rehabilitation, 101(1), 48&#x2013;52. 10.1097/PHM.0000000000001910</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001910</ArticleId><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V. T., Porcher R., Pane I., Ravaud P. (2022). Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nature Communications, 13(1), 1&#x2013;6. 10.1038/s41467-022-29513-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>UNPSA (2023, June 29). 2021 UNPSA Winners. https://publicadministration.un.org/unpsa/database/Winners/2021-Winners.</Citation></Reference><Reference><Citation>van der Maaden T., Mutubuki E. N., de Bruijn S., Leung K. Y., Knoop H., Slootweg J., Tulen A. D., Wong A., van Hoek A. J., Franz E., van den Wijngaard C. C. (2023). Prevalence and severity of symptoms 3 months after infection with SARS-CoV-2 compared to test-negative and population controls in the Netherlands. The Journal of Infectious Diseases, 227(9), 1059&#x2013;1067. 10.1093/infdis/jiac474</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac474</ArticleId><ArticleId IdType="pubmed">36477364</ArticleId></ArticleIdList></Reference><Reference><Citation>Verveen A., Wynberg E., Willigen H. V., Davidivich U., Lok A., Charante E. M. V., Jong M. D. D., Bree G. D., Prins M., Knoop H., Nieuwkerk P. T. (2022). Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: A prospective cohort study. BMC Medicine, 20(1), 422. 10.1186/s12916-022-02615-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02615-7</ArticleId><ArticleId IdType="pmc">PMC9629769</ArticleId><ArticleId IdType="pubmed">36324167</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (2023a). Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic.</Citation></Reference><Reference><Citation>World Health Organization (2023b). 
From emergency response to long-term COVID-19 disease management: Sustaining gains made during the COVID-19 pandemic.
https://www.who.int/publications/i/item/WHO-WHE-SPP-2023.1
.</Citation></Reference><Reference><Citation>World Health Organization (2021). A clinical case definition of post COVID-19 condition by a Delphi consensus (6 October 2021).
https://reliefweb.int/report/world/clinical-case-definition-post-covid-19-condition-delphi-consensus-6-october-2021?gclid=CjwKCAjw6vyiBhB_EiwAQJRoprEWL4jiv6NSLBzpKTnK- 3HuZwVEhAMEfuG2hZcizxwqaKxlIlV28RoCefcQAvD_BwE.</Citation></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators, Wulf Hanson S., Abbafati C., Aerts J. G., Al-Aly Z., Ashbaugh C., Ballouz T., Blyuss O., Bobkova P., Bonsel G., Borzakova S., Buonsenso D., Butnaru D., Carter A., Chu H., De Rose C., Diab M. M., Ekbom E., El Tantawi M., Fomin V., Vos T. (2022). Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA, 328(16), 1604&#x2013;1615. 10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng N., Zhao Y., Yan W., Li C., Lu Q., Liu L., Ni S., Mei H., Yuan K., Shi L., Li P., Fan T., Yuan J., Vitiello M. V., Kosten T., Kondratiuk A. L., Sun H., Tang X., Liu M., Lalvani A., Shi J., Bao Y., Lu L. (2023). A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: Call for research priority and action. Molecular Psychiatry, 28, 423&#x2013;433. 10.1038/s41380-022-01614-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01614-7</ArticleId><ArticleId IdType="pmc">PMC9168643</ArticleId><ArticleId IdType="pubmed">35668159</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N., Gurdasani D., O-Hara M. E., Hastie C., Roderick P., Yao G., Alwan N. A. (2022). Characteristics and impact of long COVID: Findings from an online survey. PLoS ONE, 17(3), e0264331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>